These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38881060)

  • 1. [Ⅱ. Advances in the Treatment of Adult Ph-Positive Acute Lymphoblastic Leukemia].
    Dobashi N
    Gan To Kagaku Ryoho; 2024 May; 51(5):516-519. PubMed ID: 38881060
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK
    Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ⅰ. Current Status and Future Aspect of Adult Ph-Negative Acute Lymphoblastic Leukemia].
    Hatta Y
    Gan To Kagaku Ryoho; 2024 May; 51(5):511-515. PubMed ID: 38881059
    [No Abstract]   [Full Text] [Related]  

  • 4. Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant.
    Kim K; Jabbour E; Short NJ; Kebriaei P; Kantarjian H; Ravandi F
    Curr Oncol Rep; 2021 Jun; 23(8):95. PubMed ID: 34125415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of pH-positive acute lymphoblastic leukemia].
    Ohba R; Usui N
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():465-9. PubMed ID: 23134000
    [No Abstract]   [Full Text] [Related]  

  • 6. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
    Andolina JR
    Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
    [No Abstract]   [Full Text] [Related]  

  • 7. Venetoclax and blinatumomab based chemotherapy-free treatment in a patient with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Chang J; Shen YJ; Shi T; Wang HF; Jin J; Zhu HH
    Ann Hematol; 2023 May; 102(5):1275-1277. PubMed ID: 36892592
    [No Abstract]   [Full Text] [Related]  

  • 8. Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib.
    Tiribelli M; Sperotto A; Candoni A; Simeone E; Buttignol S; Fanin R
    Leuk Res; 2009 Jan; 33(1):174-7. PubMed ID: 18471874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.
    Ottmann OG; Larson RA; Kantarjian HM; le Coutre PD; Baccarani M; Hochhaus A; Kim DW; Fan X; Novick S; Giles FJ
    Leukemia; 2013 Jun; 27(6):1411-3. PubMed ID: 23138184
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Yamamoto M; Hori T; Igarashi K; Shimada H; Tsutsumi H
    Pediatr Int; 2018 Jan; 60(1):85-87. PubMed ID: 29356285
    [No Abstract]   [Full Text] [Related]  

  • 11. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
    Uckun FM; Nachman JB; Sather HN; Sensel MG; Kraft P; Steinherz PG; Lange B; Hutchinson R; Reaman GH; Gaynon PS; Heerema NA
    Leuk Lymphoma; 1999 Mar; 33(1-2):101-6. PubMed ID: 10194126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. der(11)t(1;11)(q11;p15) as an additional cytogenetic abnormality in Ph+ adult acute lymphoblastic leukemia.
    Ma SK; Wan TS; Chan LC; Yip SF; Yeung YM
    Cancer Genet Cytogenet; 1999 Dec; 115(2):134-5. PubMed ID: 10598147
    [No Abstract]   [Full Text] [Related]  

  • 13. Imatinib for secondary Ph+ acute lymphoblastic leukemia induces response in concomitant GBM.
    De Vita S; De Matteis S; Laurenti L; Chiusolo P; Sorà F; Piccirillo N; Reddiconto G; Fiorini A; Leone G; Sica S
    Ann Oncol; 2006 Apr; 17(4):720-1. PubMed ID: 16263757
    [No Abstract]   [Full Text] [Related]  

  • 14. A balancing act: Blinatumomab use in a rare occurrence of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in an adolescent patient with Down syndrome.
    Rav ES; Wahba A; Patnaik A; Toruner G; Hittle A; Toepfer L; Roth M; Cuglievan B; Nunez C; McCall D
    Pediatr Blood Cancer; 2023 May; 70(5):e30191. PubMed ID: 36602024
    [No Abstract]   [Full Text] [Related]  

  • 15. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
    Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
    Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ravandi F; Kebriaei P
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1043-63, vi. PubMed ID: 19825452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study.
    Jabbour E; Patel K; Jain N; Duose D; Luthra R; Short NJ; Zugmaier G; San Lucas A; Velasco K; Tran Q; Zaman F; Konopleva M; Kantarjian H
    Am J Hematol; 2021 Oct; 96(10):E379-E383. PubMed ID: 34161631
    [No Abstract]   [Full Text] [Related]  

  • 18. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords.
    Swords R
    Drugs; 2007; 67(17):2655-6. PubMed ID: 18034599
    [No Abstract]   [Full Text] [Related]  

  • 19. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients.
    Jain N; Lu X; Daver N; Thakral B; Wang SA; Konoplev S; Patel K; Kanagal-Shamanna R; Valentine M; Tang G; Pemmaraju N; Jorgensen J; Kebriaei P; Nunez CA; Wierda W; Jabbour E; Roberts KG; Mullighan CG; Kantarjian H; Konopleva M
    Haematologica; 2017 Dec; 102(12):e514-e517. PubMed ID: 28860345
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Matsue K; Aoki T; Odawara J; Kimura S; Yamakura M; Takeuchi M
    Leuk Res; 2009 Jun; 33(6):867-9. PubMed ID: 18951628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.